Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Transmission and prevention news

Show

From To
Spanish vaccine induces viral control off ART in nearly 40% of recipients

A so-called ‘HIV Conserv’ vaccine has, for the first time, produced significant prolonged viral control in a large minority of recipients once they were taken off antiretroviral therapy

Published
17 February 2017
By
Gus Cairns
How should HIV self-testing services be provided?

Chairing a session on HIV self-testing at the 2017 Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle this week, Joanne Stekler said that much is already known about

Published
17 February 2017
By
Roger Pebody
Unique case of PrEP failure without drug resistance reported from Amsterdam

HIV pre-exposure prophylaxis (PrEP) appears to be nearly 100% effective if taken consistently so that there are high drug levels in the body at the time of

Published
17 February 2017
By
Gus Cairns
Oral PrEP Works Well in Women With Abnormal Vaginal Microbiota

This challenges a finding that an anti-HIV vaginal gel might not be effective in women with abnormal vaginal flora.

Published
16 February 2017
From
Poz
An 18% Decline in HIV Incidence in the US Over Six Years is Not Enough

David Holtgrave and Robert Bonacci: "At a time when some decision makers are considering possibly repealing and/or replacing the Affordable Care Act, which we know provided critical health insurance access for persons living with HIV and helped to avoid HIV transmission, we should instead be focusing as a nation on expanding critical HIV-related services and access to comprehensive care."

Published
16 February 2017
From
Huffington Post
Vaginal Ring Form of PrEP Does Not Reduce Contraceptive Effectiveness

The antiretroviral (ARV)-containing vaginal ring form of pre-exposure prophylaxis (PrEP) that reduced HIV risk in a major trial does not lower the effectiveness of hormonal birth control. This finding assuages concerns raised by previous research that the non-nucleoside reverse transcriptase inhibitor (NNRTI) class of ARVs has been associated with a lowered effectiveness of some hormonal contraceptives.

Published
16 February 2017
From
Poz
One-stop sexual health: PrEP services at your local pharmacy

Pharmacists—who work across centers that range from community clinics, to pharmacies in grocery stores, to stand-alone retail centers—may be an untapped resource as potential PrEP service providers. This was the subject up for discussion at a recent session at CROI, where two presenters shed light on the feasibility of pharmacist-delivered PrEP services.

Published
16 February 2017
From
BETA blog
New HIV infections fall in the US, but demographic and geographic disparities persist

The number of annual new HIV infections in the US fell by 18% overall since 2008, offering evidence that prevention and treatment efforts are having an impact,

Published
16 February 2017
By
Liz Highleyman
Experimental STI prophylaxis in PrEP users produces big drops in syphilis and chlamydia infections but not in gonorrhoea

Use of the antibiotic doxycycline as on-demand post-exposure prophylaxis by men who have sex with men (MSM) taking part in the Ipergay HIV pre-exposure prophylaxis (PrEP)

Published
15 February 2017
By
Gus Cairns
Commentary on U=U campaign - Follow Up on previous article 'On Fear, Infectiousness and Undetectability'

Last week, GNP+ published a statement offering an alternative perspective on the messaging of campaigns on the uninfectiousness of people living with HIV who achieve viral suppression, including the U=U (Undetectable = Untransmittable) campaign. Following reactions from supporters of the campaign, GNP+ releases the following statement clarifying our position on this important issue.

Published
15 February 2017
From
GNPPlus

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.